Evaluation Report
Evaluation Office
Tuberculosis cases, TB deaths
Let’s make Disability visible in the fight against HIV
Vor welchen Herausforderungen die Weltgesundheitsorganisation steht und wie Deutschland zu ihrer Stärkung beitragen kann.
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...ions caused by AMR organisms. With drugs not listed on the essential drugs list (EDL), problems of increased morbidity, costs of extended hospitalisation and mortality are extremely serious. The problem of susceptibility to and spread of infections caused by multidrug-resistant (MDR) infectious agents is fuelled by factors such as limited access to clean water and sanitation to ensure personal hygiene, malnutrition, and the HIV/TB epidemic.
more
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
An analysis from the perspective of the health sector in Latin America and the Caribbean
Washington, D.C., 2017
1 July 2021; Report shows big COVID-19-related HIV prevention programme service disruptions, but highlights that HIV service innovations and adaptations are possible.
A synthesis report on programme disruptions and adaptations during the COVID-19 pandemic in 2020
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Copenhagen, Denmark, 7–8 March 2017. Meeting report
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda